About us

Oncology Research International Limited (ORIL, ACN: 067 964 621) is an Australian, public, unlisted company with its registered office is in Perth, WA.

ORIL’s founder Dr Michael Wayte was diagnosed with bowel cancer in 1986. Following a demanding and restrictive vegetarian diet with specific plant-based therapies, he made a full recovery. As a result he founded ORIL with the objective of researching plant-based therapies for cancer.

ORIL utilizes an outsourcing approach to development, tailored to its specific needs at any stage of the R&D program. This is a cost-effective approach which maximises the use of existing internal skills and complements them by engaging external services on a fee for service basis as needed.

ORIL’s CEO oversees a network of outsourced organizations which includes medical research institutes, universities, hospitals and specialist contract research organizations. Where possible, and provided the organization has the expertise for the particular project, the R&D is conducted in Australia.

Address

Registered Office
Oncology Research International Limited
Level 5, 45 St George Terrace,
Perth WA 6000 Australia